XPeng (XPEV) Stock Slides as Humanoid Robot IRON Enters Production Phase

Quick Summary

• XPeng (XPEV) shares declined more than 2% even as the company’s inaugural IRON humanoid robot successfully completed automated assembly and independently exited the production facility
• Commercial rollout of IRON robots is scheduled for early 2027 across Chinese and international markets
• The production facility operates with over 80% automation in its essential processes, leveraging technology transferred from automotive manufacturing
• Dogotix, XPeng’s robotics division, secured $900 million in funding last month, achieving a valuation exceeding $6.3 billion
• UBS launched coverage of XPEV with a neutral stance and HK$47.00 target price, acknowledging robotics potential while noting electric vehicle business obstacles

The debut of XPeng’s inaugural IRON humanoid robot, which autonomously departed the production facility, failed to energize market sentiment. Shares of XPEV dropped approximately 2.2% during Wednesday trading, hovering around $10.69—dangerously close to its 52-week bottom of $10.72. The stock has surrendered more than 40% of its value since the beginning of the year.

XPeng Inc., XPEV

This achievement represents XPeng’s evolution from humanoid research and development into large-scale manufacturing capabilities. The robot successfully navigated the automated assembly sequence and independently walked away from the production line.

IRON features a biomimetic design philosophy centered on a “bone-muscle-skin” framework, incorporating a flexible spinal column, artificial muscle systems, comprehensive soft-skin covering, and hands equipped with 22 degrees of freedom. The robot operates using a physical-world foundation model supported by three Turing AI processors.

The platform integrates visual recognition, linguistic processing, and movement functions through a multi-brain artificial intelligence framework. According to XPeng, this represents their “most human-like humanoid robot” achievement to date.

XPeng’s internal engineering team conceptualized and constructed the production facility, implementing manufacturing protocols and quality assurance systems derived from automotive production environments. Automation accounts for more than 80% of the facility’s primary operations.

The company intends to launch commercial IRON deployments in domestic Chinese markets and international territories by the first quarter of 2027. Initial applications will focus on hazardous and highly repetitive operations before expanding into wider use cases.

$900 Million Investment Round

In the previous month, Dogotix—XPeng’s robotics subsidiary—completed a $900 million private equity financing round. This investment round established Dogotix’s valuation at more than $6.3 billion.

Bank of America maintained its Buy recommendation with a $19.00 price objective following the financing disclosure.

UBS Launches Coverage

Coinciding with the production announcement, UBS commenced coverage of XPEV with a neutral assessment and a price objective of HK$47.00. Analyst Paul Gong characterized XPeng as among the most aggressive robotics participants within China’s automotive manufacturing sector.

UBS employed a sum-of-the-parts methodology, allocating 30% of total value to the robotics segment. The institution recognized XPeng’s achievement in establishing $4.3 billion in robotics valuation through its fundraising efforts.

Nevertheless, UBS identified significant obstacles in the primary automotive operations, highlighting fierce market competition, supply chain disruptions, and abbreviated product lifecycle durations. XPeng continues operating without profitability, registering a negative EPS of $0.48 across the trailing twelve months.

While revenue expanded 25% to $11.1 billion, the electric vehicle division has failed to satisfy market projections.

Several other analysts have adopted more conservative positions. Freedom Broker reduced its price objective to $22.00, referencing sluggish demand and escalating pricing pressures throughout China. Barclays decreased its target to $14.00, highlighting guidance suggesting flat to minimal single-digit delivery expansion for Q3 2026.

Bernstein SocGen preserved a Market Perform designation, modifying its price target to $18.00 following broader losses.

During Q2, XPeng disclosed revenue of RMB 19.7 billion, representing an 8% year-over-year increase and 51.5% sequential growth. Gross margin performance exceeded consensus forecasts, though adjusted net profit fell short of Bloomberg projections.

The post XPeng (XPEV) Stock Slides as Humanoid Robot IRON Enters Production Phase appeared first on Blockonomi.